Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学MET Exon 14 Skipping Alterations

Mark Socinski

MD

🏢AdventHealth Cancer Institute🌐USA

Executive Medical Director, Thoracic Oncology

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Mark Socinski is a veteran thoracic oncologist who has contributed to MET exon 14 skipping treatment guidelines and community oncology implementation. His research bridges academic trial results with real-world treatment patterns for MET-altered NSCLC. He has authored influential treatment algorithms integrating molecular testing results.

Share:

🧪Research Fields 研究领域

MET exon 14 skipping
Lung cancer treatment
Immunotherapy
Bevacizumab
Community oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Mark Socinski 的研究动态

Follow Mark Socinski's research updates

留下邮箱,当我们发布与 Mark Socinski(AdventHealth Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment